This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system disorders. It acts as a key intermediate in the synthesis of various bioactive molecules, including potential therapeutic agents targeting neurological conditions. Its structural properties make it valuable for designing compounds that interact with specific receptors in the brain, aiding in the exploration of treatments for diseases such as Alzheimer's, Parkinson's, or depression. Additionally, it may be employed in preclinical studies to evaluate pharmacokinetics and pharmacodynamics, contributing to the development of novel drugs with improved efficacy and safety profiles.